A Study of Technology to Improve Glucose Control in Participants With Type 1 Diabetes



Status:Recruiting
Conditions:Diabetes, Diabetes
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - 70
Updated:3/21/2019
Start Date:February 6, 2019
End Date:May 17, 2019
Contact:This is a single site clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Email:Clinicaltrials.gov@lilly.com
Phone:1-317-615-4559

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Technology-supported, Meal-centric, Insulin Dosing for Optimized Post-prandial Glucose Control

The main purpose of this study is to determine whether combining meal, glucose, and insulin
data in a web-based system will improve management of type 1 diabetes (T1D). No study drug
will be given. The study will last about 18 weeks.


Inclusion Criteria:

- T1D by clinical diagnosis for > 3 years

- Insulin pump use > 3 months: must use one of the following pump types: Animas Ping and
Vibe, Insulet Omnipod, Medtronic 523/723 and 530G, Tandem t:slim and t:flex

- Continuous Glucose Monitor (CGM) > 3 months and current use of Dexcom G5 at least 6
out of 7 days per week

- HbA1c 7.0-9.5%

- Must have iPhone (meal-tagging app has been built on iOS)

- Personal computer for uploading of pump and CGM devices

- Willingness to follow study protocol including tagging food data

- Comfort speaking, reading, and writing English

Exclusion Criteria:

- Individuals currently using a hybrid closed-loop system (e.g., Medtronic 670G)

- Individuals planning to follow a specific diet plan for weight loss

- Inability to consume "common meals"

- Gastroparesis;

- Eating disorder

- Evidence of missed insulin meal-time insulin boluses on pump download

- Use of medications that can affect blood glucose levels (such as SGLT inhibitors,
steroid, beta agonists)

- Use of medications that affect gastric emptying (such as GLP agonists, pramlinitide)

- Alcohol abuse

- Pre-conception, pregnancy, or lactation
We found this trial at
1
site
Joslin Diabetes Center
One Joslin Place
Boston, Massachusetts 02215
617-309-2400
Principal Investigator: Elena Toschi
Phone: 617-309-1997
Joslin Diabetes Center Joslin Diabetes Center, located in Boston, Massachusetts, is the world's largest diabetes...
?
mi
from
Boston, MA
Click here to add this to my saved trials